Genomic Testing Cooperative
Visit GTC at booth #415 and learn about Liquid Trace test.
GTC offers advanced genomic profiling of DNA/RNA for solid tumors and hematologic malignancies. We also offer an LBx called Liquid Trace that anlyses cfDNA and cfRNA.
We have a fast TAT of 5-10 days and a QNS rate of <1%. Testing can be performed on FFPE, peripheral blood or bone marrow. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. GTC’s testing is covered by Medicare, most insurances and is NY state approved. We also have CE-IVD mark.